Gene vaccines

被引：97

作者：

Srivastava, IK

Liu, MA

机构：

[1] Chiron Corp, Emeryville, CA 94608 USA

[2] Transgene SA, Strasbourg, France

来源：

ANNALS OF INTERNAL MEDICINE | 2003年 / 138卷 / 07期

关键词：

D O I：

10.7326/0003-4819-138-7-200304010-00011

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Gene vaccines are a new approach to immunization and immunotherapy in which, rather than a live or inactivated organism (or a subunit thereof), one or more genes that encode proteins of the pathogen are delivered. The goal of this approach is to generate immunity against diseases for which traditional vaccines and treatments have not worked, to improve vaccines, and to treat chronic diseases. Gene vaccines make use of advances in immunology and molecular biology to more specifically tailor immune responses (cellular or humoral, or both) against selected antigens. They are still under development in research and clinical trials. The mechanisms for inducing cellular (as opposed to humoral) responses against a particular antigen have been elucidated. Gene vaccines provide a means to generate specific cellular responses while still generating antibodies, if desired. In addition, by delivering only the genes that encode the particular proteins against which a protective or therapeutic immune response is desired, the potential limitations and risks of certain other approaches can be avoided. This article describes the rationale for, immunologic mechanisms involved in, and design of gene vaccines under development. Preclinical and clinical studies of these vaccines are discussed for various clinical applications, focusing on infectious diseases.

引用

页码：550 / 559

页数：10

共 110 条

[1] Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen [J].

Allen, TM ;

Vogel, TU ;

Fuller, DH ;

Mothé, BR ;

Steffen, S ;

Boyson, JE ;

Shipley, T ;

Fuller, J ;

Hanke, T ;

Sette, A ;

Altman, JD ;

Moss, B ;

McMichael, AJ ;

Watkins, DI .

JOURNAL OF IMMUNOLOGY, 2000, 164 (09) :4968-4978

[2] Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine [J].

Amara, RR ;

Villinger, F ;

Altman, JD ;

Lydy, SL ;

O'Neil, SP ;

Staprans, SI ;

Montefiori, DC ;

Xu, Y ;

Herndon, JG ;

Wyatt, LS ;

Candido, MA ;

Kozyr, NL ;

Earl, PL ;

Smith, JM ;

Ma, HL ;

Grimm, BD ;

Hulsey, ML ;

Miller, J ;

McClure, HM ;

McNicholl, JM ;

Moss, B ;

Robinson, HL .

SCIENCE, 2001, 292 (5514) :69-74

[3] Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques [J].

Baba, TW ;

Liska, V ;

Khimani, AH ;

Ray, NB ;

Dailey, PJ ;

Penninck, D ;

Bronson, R ;

Greene, MF ;

McClure, HM ;

Martin, LN ;

Ruprecht, RM .

NATURE MEDICINE, 1999, 5 (02) :194-203

[4] The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region [J].

Barnet, SW ;

Lu, S ;

Srivastava, I ;

Cherpelis, S ;

Gettie, A ;

Blanchard, J ;

Wang, S ;

Mboudjeka, I ;

Leung, L ;

Lian, Y ;

Fong, A ;

Buckner, C ;

Ly, A ;

Hilt, S ;

Ulmer, J ;

Wild, CT ;

Mascola, JR ;

Stamatatos, L .

JOURNAL OF VIROLOGY, 2001, 75 (12) :5526-5540

[5] Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys [J].

Barouch, DH ;

Craiu, A ;

Kuroda, MJ ;

Schmitz, JE ;

Zheng, XX ;

Santra, S ;

Frost, JD ;

Krivulka, GR ;

Lifton, MA ;

Crabbs, CL ;

Heidecker, G ;

Perry, HC ;

Davies, ME ;

Xie, H ;

Nickerson, CE ;

Steenbeke, TD ;

Lord, CI ;

Montefiori, DC ;

Strom, TB ;

Shiver, JW ;

Lewis, MG ;

Letvin, NL .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (08) :4192-4197

[6] Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination [J].

Barouch, DH ;

Santra, S ;

Schmitz, JE ;

Kuroda, MJ ;

Fu, TM ;

Wagner, W ;

Bilska, M ;

Craiu, A ;

Zheng, XX ;

Krivulka, GR ;

Beaudry, K ;

Lifton, MA ;

Nickerson, CE ;

Trigona, WL ;

Punt, K ;

Freed, DC ;

Guan, LM ;

Dubey, S ;

Casimiro, D ;

Simon, A ;

Davies, ME ;

Chastain, M ;

Strom, TB ;

Gelman, RS ;

Montefiori, DC ;

Lewis, MG ;

Emini, EA ;

Shiver, JW ;

Letvin, NL .

SCIENCE, 2000, 290 (5491) :486-492

[7] Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys [J].

Barouch, DH ;

Craiu, A ;

Santra, S ;

Egan, MA ;

Schmitz, JE ;

Kuroda, MJ ;

Fu, TM ;

Nam, JH ;

Wyatt, LS ;

Lifton, MA ;

Krivulka, GR ;

Nickerson, CE ;

Lord, CI ;

Moss, B ;

Lewis, MG ;

Hirsch, VM ;

Shiver, JW ;

Letvin, NL .

JOURNAL OF VIROLOGY, 2001, 75 (05) :2462-2467

[8] Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity [J].

Biragyn, A ;

Tani, K ;

Grimm, MC ;

Weeks, S ;

Kwak, LW .

NATURE BIOTECHNOLOGY, 1999, 17 (03) :253-258

[9] DNA immunization against experimental genital herpes simplex virus infection [J].

Bourne, N ;

Stanberry, LR ;

Bernstein, DI ;

Lew, D .

JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (04) :800-807

[10]

Boyer J D, 1998, Dev Biol Stand, V95, P147

← 1 2 3 4 5 6 7 8 9 10 →